GPR173 agonist phoenixin 20 promotes osteoblastic differentiation of MC3T3-E1 cells
Osteogenic differentiation is critical to bone homeostasis, and its imbalance plays a key role in the progression of osteoporosis. Osteoblast cells are responsible for synthesizing new bone tissue, and understanding how to control osteoblastic differentiation is vital to the treatment of osteoporosi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950309/ https://www.ncbi.nlm.nih.gov/pubmed/33196456 http://dx.doi.org/10.18632/aging.103717 |
_version_ | 1783663563225694208 |
---|---|
author | Gu, Zhengtao Xie, Denghui Ding, Rui Huang, Caiqiang Qiu, Yiyan |
author_facet | Gu, Zhengtao Xie, Denghui Ding, Rui Huang, Caiqiang Qiu, Yiyan |
author_sort | Gu, Zhengtao |
collection | PubMed |
description | Osteogenic differentiation is critical to bone homeostasis, and its imbalance plays a key role in the progression of osteoporosis. Osteoblast cells are responsible for synthesizing new bone tissue, and understanding how to control osteoblastic differentiation is vital to the treatment of osteoporosis. Herein, we show that GPR173 signaling is involved in the regulation of osteoblastic differentiation in MC3T3-E1 cells. Our data reveals that GPR173 is abundantly expressed in MC3T3-E1 cells, and its expression is inducible upon the introduction of osteogenic media. The activation of GPR173 by its selective agonist phoenixin 20 induces the expression of several osteoblast signature genes including collagen type 1 alpha 1 (Col-I), osteocalcin (OCN), alkaline phosphatase (ALP) as well as increased matrix mineralization and ALP activity, suggesting that the activation of GPR173 promotes osteoblastic differentiation. Moreover, we show that the effect of phoenixin 20 is mediated by its induction on the key regulator runt-Related Transcription Factor 2 (Runx2). Mechanistically, we display that the action of phoenixin 20 requires the activation of MAPK kinase p38, and deactivation of p38 by its inhibitor SB203580 weakens the phoenixin 20-mediated induction of RUNX-2, ALP, and matrix mineralization. Silencing of GPR173 attenuates phoenixin 20-mediated osteoblastic differentiation, indicating its dependence on the receptor. Collectively, our study reveals a new role of GPR173 and its agonist phoenixin 20 in osteoblastic differentiation. |
format | Online Article Text |
id | pubmed-7950309 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Impact Journals |
record_format | MEDLINE/PubMed |
spelling | pubmed-79503092021-03-23 GPR173 agonist phoenixin 20 promotes osteoblastic differentiation of MC3T3-E1 cells Gu, Zhengtao Xie, Denghui Ding, Rui Huang, Caiqiang Qiu, Yiyan Aging (Albany NY) Research Paper Osteogenic differentiation is critical to bone homeostasis, and its imbalance plays a key role in the progression of osteoporosis. Osteoblast cells are responsible for synthesizing new bone tissue, and understanding how to control osteoblastic differentiation is vital to the treatment of osteoporosis. Herein, we show that GPR173 signaling is involved in the regulation of osteoblastic differentiation in MC3T3-E1 cells. Our data reveals that GPR173 is abundantly expressed in MC3T3-E1 cells, and its expression is inducible upon the introduction of osteogenic media. The activation of GPR173 by its selective agonist phoenixin 20 induces the expression of several osteoblast signature genes including collagen type 1 alpha 1 (Col-I), osteocalcin (OCN), alkaline phosphatase (ALP) as well as increased matrix mineralization and ALP activity, suggesting that the activation of GPR173 promotes osteoblastic differentiation. Moreover, we show that the effect of phoenixin 20 is mediated by its induction on the key regulator runt-Related Transcription Factor 2 (Runx2). Mechanistically, we display that the action of phoenixin 20 requires the activation of MAPK kinase p38, and deactivation of p38 by its inhibitor SB203580 weakens the phoenixin 20-mediated induction of RUNX-2, ALP, and matrix mineralization. Silencing of GPR173 attenuates phoenixin 20-mediated osteoblastic differentiation, indicating its dependence on the receptor. Collectively, our study reveals a new role of GPR173 and its agonist phoenixin 20 in osteoblastic differentiation. Impact Journals 2020-11-10 /pmc/articles/PMC7950309/ /pubmed/33196456 http://dx.doi.org/10.18632/aging.103717 Text en Copyright: © 2020 Gu et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/3.0/) (CC BY 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Paper Gu, Zhengtao Xie, Denghui Ding, Rui Huang, Caiqiang Qiu, Yiyan GPR173 agonist phoenixin 20 promotes osteoblastic differentiation of MC3T3-E1 cells |
title | GPR173 agonist phoenixin 20 promotes osteoblastic differentiation of MC3T3-E1 cells |
title_full | GPR173 agonist phoenixin 20 promotes osteoblastic differentiation of MC3T3-E1 cells |
title_fullStr | GPR173 agonist phoenixin 20 promotes osteoblastic differentiation of MC3T3-E1 cells |
title_full_unstemmed | GPR173 agonist phoenixin 20 promotes osteoblastic differentiation of MC3T3-E1 cells |
title_short | GPR173 agonist phoenixin 20 promotes osteoblastic differentiation of MC3T3-E1 cells |
title_sort | gpr173 agonist phoenixin 20 promotes osteoblastic differentiation of mc3t3-e1 cells |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7950309/ https://www.ncbi.nlm.nih.gov/pubmed/33196456 http://dx.doi.org/10.18632/aging.103717 |
work_keys_str_mv | AT guzhengtao gpr173agonistphoenixin20promotesosteoblasticdifferentiationofmc3t3e1cells AT xiedenghui gpr173agonistphoenixin20promotesosteoblasticdifferentiationofmc3t3e1cells AT dingrui gpr173agonistphoenixin20promotesosteoblasticdifferentiationofmc3t3e1cells AT huangcaiqiang gpr173agonistphoenixin20promotesosteoblasticdifferentiationofmc3t3e1cells AT qiuyiyan gpr173agonistphoenixin20promotesosteoblasticdifferentiationofmc3t3e1cells |